Beacon Intelligence to accelerate growth in life sciences R&D intelligence with new investment from Corten Capital
Beacon Intelligence has received a majority investment from Corten Capital to support its growth in life sciences R&D intelligence. This investment will allow Beacon to operate independently and continue expanding its data platform, which is used by major pharmaceutical companies to enhance drug development decisions. The move underscores Beacon's role as a key intelligence provider in the life sciences sector.
Read disclosure →